Literature DB >> 12021928

Amyloidosis of the breast.

Christoph Röcken1, Hartmut Kronsbein, Knut Sletten, Albert Roessner, Roland Bässler.   

Abstract

We report on three cases of amyloidosis of the breast, two of which coincided with breast cancer. Patient no. 1, a 60-year-old woman, presented with two mass lesions measuring 2 cm in diameter, one in each breast. Histologically, a tubulo-lobular carcinoma was found in the left breast accompanied by vascular, interstitial, and periductal amyloid deposits; the lesion in the right breast consisted of amyloid deposits only. Patient no. 2, an 86-year-old woman, presented with an ulcerated breast tumor measuring 5 cm in diameter on the left side. A poorly differentiated invasive ductal carcinoma was found in the mastectomy specimen, and it coincided with interstitial and vascular amyloid deposits. In both patients, tumor cells had invaded the amyloid deposits. Patient no. 3, a 73-year-old woman, presented with a mass measuring 5 x 3 x 3 cm in her left breast. Fibrocystic changes, as well as interstitial and periductal amyloid deposits, were found histologically. In each case electron microscopy showed rigid, non-branching fibrils of indefinite length and measuring 10-12 nm in diameter; these were consistent with amyloid fibrils. Clinical data, immunohistochemistry, and/or amino acid sequencing of the fibril proteins extracted from formalin-fixed and paraffin-embedded tissue specimens provided evidence that the amyloid deposits were of immunoglobulin light chain origin in all three cases. A review of the literature revealed that kappa-light chain has been described more frequently than lambda-light chain in the breast and that there are no specific clinical or radiological symptoms of amyloidosis affecting the breast; a diagnosis can be achieved only by histology.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12021928     DOI: 10.1007/s00428-001-0555-z

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  9 in total

1.  Tumorous amyloidosis of the breast associated with disseminated malignant lymphoma.

Authors:  P C W Lui; L-M Pang; T-T Hlaing; G M K Tse
Journal:  J Clin Pathol       Date:  2004-03       Impact factor: 3.411

2.  [Amyloid diagnostics in rheumatic diseases].

Authors:  C Röcken; J Ernst
Journal:  Pathologe       Date:  2006-11       Impact factor: 1.011

3.  Primary breast amyloidosis presenting as microcalcifications only.

Authors:  Youngsub Shim; Min Jung Kim; Han Suk Ryu; Sung Hee Park
Journal:  Korean J Radiol       Date:  2013-08-30       Impact factor: 3.500

4.  Primary amyloidosis of the breast presenting as a solitary nodule: case report and review of the literature.

Authors:  Mary E Huerter; Rasheed Hammadeh; Quan Zhou; Asher Weisberg; Adam I Riker
Journal:  Ochsner J       Date:  2014

Review 5.  Amyloid in surgical pathology.

Authors:  Christoph Röcken; Knut Sletten
Journal:  Virchows Arch       Date:  2003-06-11       Impact factor: 4.064

Review 6.  Severe diffuse systemic amyloidosis with involvement of the pharynx, larynx, and trachea: CT and MR findings.

Authors:  R Gilad; P Milillo; P M Som
Journal:  AJNR Am J Neuroradiol       Date:  2007-09       Impact factor: 3.825

7.  Amyloidosis of the Breast with Multicentric DCIS and Pleomorphic Invasive Lobular Carcinoma in a Patient with Underlying Extranodal Castleman's Disease.

Authors:  David Chiang; Michael Lee; Pauline Germaine; Lydia Liao
Journal:  Case Rep Radiol       Date:  2013-02-04

8.  Accumulation of amyloid beta (Aβ) and amyloid precursor protein (APP) in tumors formed by a mouse xenograft model of inflammatory breast cancer.

Authors:  Astrid Zayas-Santiago; Michelle M Martínez-Montemayor; Jadier Colón-Vázquez; Gabriela Ortiz-Soto; Jose G Cirino-Simonet; Mikhail Inyushin
Journal:  FEBS Open Bio       Date:  2021-10-26       Impact factor: 2.693

Review 9.  Localized primary amyloidosis of the breast: a case report and review of the literature.

Authors:  Wakako Tsuji; Eiji Takeuchi; Satoshi Oka; Taro Yamashita; Fumiaki Yotsumoto
Journal:  BMC Surg       Date:  2016-09-13       Impact factor: 2.102

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.